-
Non Regulatory November 11, 2024Vivesto’s Paccal Vet receives Limited Market classification in EU
-
Regulatory November 7, 2024Vivesto signs Apealea option agreement with Zhida Pharmaceutical
-
Non Regulatory July 1, 2024Vivesto receives positive Cantrixil preclinical efficacy data
Interim Report Q2 2024
Vivesto published its Q2 report for 2024 on August 22, 2024, at 08.00 am CEST.
(in Swedish)